The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This report examines the exposure to, and belief in, health misinformation among Hispanic adults, as well as the media sources they use and the trust they place in health information received from various outlets. It is a companion to the KFF Health Misinformation Tracking Poll Pilot.
As Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it. Based on interviews with nearly 80 representatives from private insurance plans, state Medicaid programs, chain pharmacies, and other key groups, the report provides a deeper view into the operational challenges in expanding access to…
This volume highlights how a report criticized for flawed methodology is influencing renewed efforts to restrict access to mifepristone; a federal plan to study the causes of autism that could be contributing to stigma by over-emphasizing environmental toxins; and the resurgence of false claims about fetal tissue in vaccines.
This State and Federal Reproductive Rights Litigation tracker aggregates information about ongoing litigation regarding abortion bans and restrictions, FDA approval of Mifepristone (an abortion pill) and other federal regulations.
“[Indiana, Oklahoma, and Nebraska] are the only states that took additional state-level action to exclude Planned Parenthood from Medicaid during the year the federal ban has been in effect. With the expiration of the national ban on Planned Parenthood Medicaid reimbursement and the Medina decision clearing the way for states to exclude Planned Parenthood from Medicaid, other states may follow suit.”
© 2026 KFF